NCT04730453

ENB-guided Ablation Therapy Combined With VATS in the Treatment of MPLC

Electromagnetic Navigation Bronchoscopy Guided Ablation Therapy Combined With VATS in the Treatment of Multiple Primary Lung Cancers

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 30 (estimated)
• Sponsor: Shanghai Chest Hospital · Academic / Other
• Sex: All
• Age: 18 Minutes
• Healthy volunteers: —

Summary

The study is designed as a prospective trial whose purpose is to evaluate the effectiveness and safety of ENB-guided ablation therapy combined with VATS in the treatment of multiple primary lung cancers (MPLC).

Detailed description

Patients will be first screened, and only after meeting all the selection criteria, not meeting any exclusion criteria, and signing the informed consent, could they be enrolled in the group to receive ENB-guided ablation therapy combined with VATS. The primary endpoint is objective response rate (ORR). The secondary endpoints include progression-free survival (PFS), overall survival (OS) and safety.

Conditions

• Lung Cancer

Interventions

Type	Name	Description
PROCEDURE	ENB-guided ablation therapy combined with VATS	After receiving multidisciplinary assessments, Lesion A will receive ENB-guided ablation therapy and Lesion B will receive VATS at the same time.

Timeline

• Start date: 2020-07-24
• Primary completion: 2025-01-01
• Completion: 2025-12-01
• First posted: 2021-01-29
• Last updated: 2021-01-29

Locations

1 site across 1 country: China